Neuropeptide Y receptor expression in human primary ovarian neoplasms.

Neuropeptide Y receptor expression in human primary ovarian neoplasms.

Item
http://www.wikidata.org/entity/Q40614679
Network-based survival analysis reveals subnetwork signatures for predicting outcomes of ovarian cancer treatment.Novel dimeric DOTA-coupled peptidic Y1-receptor antagonists for targeting of neuropeptide Y receptor-expressing cancers.Neuropeptide Y protects kidney against cisplatin-induced nephrotoxicity by regulating p53-dependent apoptosis pathway.Radiometallated peptides for molecular imaging and targeted therapy.Central and peripheral nervous systems: master controllers in cancer metastasis.Neuropeptide Y receptors: a promising target for cancer imaging and therapy.Molecular imaging probes derived from natural peptides.Neuropeptide Y stimulates proliferation and migration in the 4T1 breast cancer cell line.[³H]UR-MK136: a highly potent and selective radioligand for neuropeptide Y Y₁ receptors.On the terminal homologation of physiologically active peptides as a means of increasing stability in human serum--neurotensin, opiorphin, B27-KK10 epitope, NPY.Comparative gene expression profiling in human cumulus cells according to ovarian gonadotropin treatments.
P2860

Neuropeptide Y receptor expression in human primary ovarian neoplasms.

Item
http://www.wikidata.org/entity/Q40614679
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Neuropeptide Y receptor expression in human primary ovarian neoplasms.
@en
type
label
Neuropeptide Y receptor expression in human primary ovarian neoplasms.
@en
prefLabel
Neuropeptide Y receptor expression in human primary ovarian neoplasms.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Neuropeptide Y receptor expression in human primary ovarian neoplasms.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P698